Final 3-Year Results from the EVIDENS Study, an Observational Study of Nivolumab in Non-Small Cell Lung Cancer

Fabrice Barlesi,Adrien Dixmier, Didier Debieuvre,Christophe Raspaud, Jean-Bernard Auliac, Nicolas Benoit, Pierre Bombaron, Denis Moro-Sibilot, Bernard Asselain,Clarisse Audigier-Valette, Florence Brellier, François-Emery Cotté, Yaacoub Khalife,Maurice Pérol

Oncoimmunology（2025）

Cited 0|Views1

Key words

EVIDENS,France,nivolumab,non-small cell lung cancer,observational study

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined